Eric Risberg / AP

Gilead Sciences said Monday it will buy Kite Pharma for $11.9 billion. Kite makes a breakthrough therapy that uses a patient's own immune cells to attack cancer cells, which is expected to get FDA approval this fall.

Why it matters: Gilead has been flying high since it bought Pharmasset in similar-sized deal in 2011, which gave Gilead its blockbuster hepatitis C drugs. But investors have been clamoring for Gilead to use its mountain of cash on a new deal. The acquisition of Kite adds another potentially game-changing drug to Gilead's business.

Yes, but: The price of Kite's cancer treatments (and similar treatments made by other drug companies) is a "quantum leap more expensive than other cancer drugs," Kaiser Health News recently reported. Gilead has already faced criticism for setting high list prices for its hepatitis C drugs.

Go deeper

Updated 19 mins ago - Politics & Policy

Supreme Court blocks Alabama curbside voting measure

Photo: Mark Wilson/Getty Images

The Supreme Court on Wednesday evening blocked a lower court order that would have allowed voters to cast ballots curbside at Alabama polling places on Election Day.

Whit it matters: With less than two weeks until Election Day, the justices voted 5-3 to reinstate the curbside voting ban and overturn a lower court judge's ruling designed to protect people with disabilities.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Senate Democrats block vote on McConnell's targeted COVID relief bill McConnell urges White House not to strike stimulus deal before election.
  2. Economy: Why the stimulus delay isn't a crisis (yet).
  3. Health: New York reports most COVID cases since MayStudies show drop in coronavirus death rate — The next wave is gaining steam.
  4. Education: Schools haven't become hotspots — San Francisco public schools likely won't reopen before the end of the year.
  5. World: Spain becomes first nation in Western Europe to exceed 1 million cases.

U.S. officials: Iran and Russia aim to interfere in election

Iran and Russia have obtained voter registration information that can be used to undermine confidence in the U.S. election system, Director of National Intelligence John Ratcliffe announced at a press conference Wednesday evening.

Why it matters: The revelation comes roughly two weeks before Election Day. Ratcliffe said Iran has sent threatening emails to Democratic voters this week in states across the U.S. and spread videos claiming that people can vote more than once.